![]() ![]() Patients are at the front and center of our decision-making and innovations. ![]() To transform lives for generations, which is our company’s purpose, we need to be excellent throughout and become leaders and leading experts in medicine, bringing life-changing treatments to patients faster than ever before. We must move forward to deliver for our patients and deliver on our promise to be constructively disruptive to get the best outcomes and reach our medicine goals. Scholze: As an organization, we cannot afford to stand still. HMS: How does UME support Boehringer Ingelheim’s goals?ĭr. In the first year alone, approximately 950 learners were able to enroll. As this is a unified goal and need for all of medicine, we wanted to give as many people access to the program as possible. Our vision to achieve this goal was to create a best-in-class learning organization to bolster our culture of excellence and drive a culture of continuous learning, while providing the skills and competencies our people in medicine need in a period of transformation across the organization and in the health care environment. Scholze: Our mission is to create the next generation of leaders and leading experts in medicine, primarily in clinical development and medical affairs roles, who can bring innovative treatments to patients faster than ever before. HMS: What are the goals of the University of Medicine Excellence?ĭr. We sat down with Guido Scholze, the global head of UME at Boehringer Ingelheim, to discuss the programs’ successes and how they fit into Boehringer Ingelheim’s strategic goals. Of the learners, 69 went on to complete ‘AccelerateEX’, extending the educational program to include in-person components at HMS and at the company’s headquarters in Ingelheim. Accelerate covers a range of topics, including patient centricity, various aspects of leadership and new ways of working, digital technologies and real-world evidence. The learners are drawn from multiple medicine disciplines across Boehringer Ingelheim, including clinical development & operations, regulatory affairs, medical affairs, biostatistics & data sciences and many other related functions, including some outside of medicine. Since the launch, nearly 1,000 learners have already completed Accelerate. UME’s first and flagship program is ‘Accelerate,’ an ambitious program intended to reach virtually every person in Boehringer Ingelheim’s wider Medicine organization. Boehringer Ingelheim, a global pharmaceutical company, co-designs and co-delivers the executive education program with Harvard Medical School (HMS) Corporate Learning. As part of an organizational transformation, Boehringer Ingelheim launched the University of Medicine Excellence (UME) in July 2021 according to their purpose of ‘Transforming Lives for Generations’ and commitment to employee development and continuous learning. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |